AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on July 1, 2026

IQM Quantum Computers and Real Asset Acquisition Corp. complete the combination; trading in IQM’s ADSs and IQM Warrants on Nasdaq Stock Market LLC commences on July 2, 2026
IQM Quantum Computers ja Real Asset Acquisition Corp. toteuttavat yhdistymisen; kaupankäynti IQM:n ADS-osaketalletustodistuksilla ja IQM:n Warranteilla Nasdaq Stock Market LLC -markkinapaikalla alkaa 2.7.2026
200+ Brands, 100+ Speakers Confirmed for Forex Expo Dubai 2026
Alvotech further strengthens liquidity by securing term loan facility of $75 million
Willis launches CyMax Facility, a primary and excess facility aimed at SMEs and middle market companies in the EMEA region
Oxford-Harrington Rare Disease Centre Strengthens Rare Childhood Cancer Programme Through Appointment of New Little Princess Trust Professor of Paediatric Oncology
Less Than Half of Organizations Can Reliably Tell If There‘s a Real Person Behind an Online Identity Check
17a-4 Announces New DataParser Capabilities for Microsoft Teams to Collect Call Recordings, Transcripts and SMS
DNB Goes Live on the nCino Platform to Modernise and Scale Corporate Lending Across International Markets
VulNow Becomes a CVE Numbering Authority under ENISA Root
Vocalbeats.AI Joins SGTech’s Singapore Enterprise Chapter
Press Release: Availability of the aide-mémoire for Q2 2026 results
Communiqué de presse : Mise en ligne du document «Q2 2026 aide-mémoire »
Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment
Nicox : Demande d’autorisation de mise sur le marché de NCX 470 soumise aux Etats-Unis par Kowa, avec un paiement d’étape de 3 millions d’euros associé
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
Santhera gibt Topline-Ergebnisse der klinischen Phase-1-Studie von Catalyst Pharmaceuticals zu AGAMREE® bekannt
Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.